PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 133 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $17,446,000 | -5.0% | 180,000 | -10.0% | 2.38% | +2.2% |
| Q2 2014 | $18,372,000 | +31.2% | 200,000 | 0.0% | 2.33% | +50.1% |
| Q1 2014 | $13,998,000 | -16.4% | 200,000 | -31.3% | 1.55% | -13.6% |
| Q4 2013 | $16,735,000 | +2.0% | 291,095 | -14.7% | 1.79% | -10.9% |
| Q3 2013 | $16,405,000 | +13.2% | 341,139 | -31.7% | 2.01% | +3.0% |
| Q2 2013 | $14,495,000 | – | 499,829 | – | 1.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |